| Antimicrobial Resistance of Bacteria Isolated From Patients With Cancer |
| Friday, September 25, 2026 12:25 PM |
| Cancer patients are at high risk of developing infections caused by multidrug-resistant (MDR) microorganisms. Monitoring antimicrobial resistance (AMR) is essential for guiding treatment in this vulnerable population. This study aimed to evaluate AMR patterns and temporal evolution among clinical bacterial isolates-comparing pre-pandemic (2016-2019) versus pandemic (2020-2021) periods and care settings (outpatient vs. inpatient)-recovered from cancer patients at a tertiary care center in Guerrero, Mexico. Read more. |